ARCHIVES

Low Adiponcetin Hormone Levels Linked to Increased Cancer Risk

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

Greenberg: More Work Needs to be Done

November 7, 2014

NCI T BE More Flexible In Funding RFAs Above Paylines

June 23, 1989

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006

Guest Editorial By Gregory Reaman: Memories Of A Merger Past

July 15, 2011

US Oncology Clarifies Role of Pharmacy Committee

January 24, 2003

Requiring Survival Data Was Logical In 1950s, Not Today, Broder Says

January 13, 1989